Edition:
United Kingdom

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

24.99USD
13 Dec 2017
Change (% chg)

$0.24 (+0.97%)
Prev Close
$24.75
Open
$24.76
Day's High
$25.10
Day's Low
$24.65
Volume
51,046
Avg. Vol
81,630
52-wk High
$33.10
52-wk Low
$23.04

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems Inc reports Q1 loss per share $0.06
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results.Q1 loss per share $0.06.Q1 revenue $49.7 million versus I/B/E/S view $51 million.Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S.Sees Q2 2018 loss per share $0.03 to $0.06.Sees FY 2018 revenue $226 million to $233 million.Sees Q2 2018 revenue $52.5 million to $54 million.Q2 earnings per share view $-0.01, revenue view $55.1 million -- Thomson Reuters I/B/E/S.FY2018 revenue view $227.6 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems names Scott Ward as CEO
Tuesday, 16 Aug 2016 

Cardiovascular Systems Inc : Cardiovascular Systems names Scott Ward as CEO . Cardiovascular Systems Inc says Scott R. Ward, company's new chairman and chief executive officer, effective immediately .Scott Ward has been serving as chairman since November 2014 and interim president and CEO since November 2015.  Full Article

Cardiovascular Systems reports Q4 loss per share $0.15
Wednesday, 3 Aug 2016 

Cardiovascular Systems Inc : Q4 revenue $48.5 million versus I/B/E/S view $46 million . Q4 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S . Quarter financial results . Q4 loss per share $0.15 . Sees q1 revenue in a range of $48.0 million to $49.5 million . Sees q1 loss per common share ranging from $0.18 to $0.21 .Q1 earnings per share view $-0.22, revenue view $45.9 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces settlement agreement to resolve investigation by DOJ, qui tam complaint filed by Travis Thams
Tuesday, 28 Jun 2016 

Cardiovascular Systems Inc : Settlement agreement with United States of America, to resolve investigation by DOJ, qui tam complaint filed by Travis Thams . Under the settlement agreement, the company will pay $8 million - SEC filing .Will also be required to pay Thams' reasonable expenses, costs and attorney’s fees, which amount has not yet been determined.  Full Article

Class Action Lawsuit Filed Against Cardiovascular Systems Inc - ACSWIR
Monday, 21 Mar 2016 

Cardiovascular Systems Inc:The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has filed a shareholder class action lawsuit in the United States District Court for the District of Minnesota against Cardiovascular Systems - ACSWIR.on behalf of purchasers of the Company's common stock between September 12, 2011 and January 21, 2016, inclusive (the "Class Period").The shareholder class action complaint alleges that CSI and certain of its executive officers made a series of false and misleading statements and failed to disclose material adverse facts about the Company's business and operations.Specifically, the defendants are alleged to have falsely touted CSI's code of ethics while failing to disclose that the Company relied upon illegal kickbacks, off-label promotions, and other violations of applicable laws and regulations in order to drive sales of its products.  Full Article

Cardiovascular Systems Inc gives Q3 2016 guidance
Thursday, 21 Jan 2016 

Cardiovascular Systems Inc:Anticipates Q3 2016 Revenue in a range of $40.5 million to $42 million.Anticipates Q3 2016 Net loss in the range of $(13.7) million to $(14.6) million, or loss per common share ranging from $(0.42) to $(0.45).  Full Article

BRIEF-Cardiovascular Systems Inc reports Q1 loss per share $0.06

* Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results